Form 4: Molina Healthcare Director Ronna Romney Acquires Shares Under Equity Incentive Plan

Director Ronna Romney acquired 189 shares of Molina Healthcare, Inc. common stock on January 1, 2025, as part of the company's 2019 Equity Incentive Plan.

Summary

• Ronna Romney, a director of Molina Healthcare, Inc., acquired 189 shares of common stock on January 1, 2025.
• The acquisition was made under the company's 2019 Equity Incentive Plan as part of her compensation for serving as a director.
• The shares were granted at a price of $291.05 per share, based on the closing price of Molina Healthcare's common stock on December 31, 2024.
• The grant this quarter for services as a Director is for 189 shares of the Issuer's common stock.
• Following the transaction, Ronna Romney beneficially owns 17,483 shares indirectly through a trust.
• Jeff D. Barlow, acting as attorney-in-fact, signed the Form 4 on behalf of Ronna Romney.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The equity grant suggests confidence in the company's future performance.

Positives

• The equity incentive plan aligns the interests of directors with those of shareholders.
• Director compensation includes equity, which can incentivize long-term value creation.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Director stock ownership is a common practice in publicly traded companies to align the interests of management and shareholders. Equity grants are a typical component of director compensation packages.

Comparison to Industry Standards

• Director compensation packages vary across the healthcare industry, but equity grants are a common component.
• Comparing Molina Healthcare's director compensation to peers like UnitedHealth Group, Anthem, or Centene would provide a better understanding of its relative competitiveness.
• The size of the equity grant ($55,000 per quarter) can be compared to industry averages for companies of similar size and market capitalization.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning director interests with shareholder value.
• The equity grant serves as part of the director's compensation.

Key Dates